BioNTech SE Announces New CFO Appointment

BioNTech SE has officially announced the appointment of Ramon Zapata-Gomez as its new Chief Financial Officer, starting July 1, 2025. This strategic move marks a significant transition as Zapata-Gomez takes over from Jens Holstein, who is set to retire after his current term.

A Seasoned Leader Joins BioNTech

Currently serving as the CFO at Novartis's global biomedical research unit, Zapata-Gomez brings a wealth of experience from his roles across North America, Europe, and Latin America. His extensive background in finance and leadership is expected to drive BioNTech's financial strategies forward.

Leadership and Vision for the Future

Helmut Jeggle, Chairman of the Supervisory Board, praised Zapata-Gomez as "an accomplished leader with deep finance expertise", highlighting his ability to understand market dynamics and lead teams effectively. Zapata-Gomez expressed his enthusiasm for joining BioNTech, stating he is "eager to contribute" to the company's mission of improving patients' lives through innovative healthcare solutions.